Lazard Asset Management »

United Therapeutics Corporation shares owned by Lazard Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $2.7M 51k 53.40

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Alphabet Inc A Common Stock (GOOGL)
Intercontinen Common Stock (ICE)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Unitedhealth Gr Common Stock (UNH)
Accenture Common Stock (ACN)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Exelon Corp Common Stock (EXC)
Aon Plc/ireland Common Stock (AON)
Exxon Mobil Common Stock (XOM)
Broadcom Common Stock (AVGO)

View all positions for Lazard Asset Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation